半岛bd体育手机客户端 说明
包装
5, 25 mg in glass bottle
生化/生理作用
CP-135807 is a selective 5-HT1D agonist.
其他说明
This compound was developed by Pfizer for Neuroscience research. To learn more about Sigma′s partnership with Pfizer and view other authentic, high-quality Pfizer compounds, visit sigma.com/bsm-pfizer.
To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
法律信息
Sold for research purposes under agreement from Pfizer Inc.
Pfizer is a registered trademark of Pfizer, Inc.
基本信息
| 经验(实验)分子式 | C19H21N5O2 |
| 分子量 | 351.40 |
| MDL编号 | MFCD00921453 |
| PubChem化学物质编号 | 329823712 |
| NACRES | NA.77 |
半岛bd体育手机客户端 性质
| 质量水平 | 100 |
| 测定 | ≥98% (HPLC) |
| 形式 | powder |
| 旋光性 | [α]/D +100 to +120°, c = 0.025 mg/mL in methanol |
| manufacturer/tradename | Pfizer? |
| 颜色 | brown-red |
| 溶解性 | DMSO: ≥5 mg/mL |
| 创始人 | Pfizer |
| 储存温度 | room temp |
| SMILES string | CN1CCC[C@@H]1Cc2c[nH]c3ccc(Nc4ncccc4[N+]([O-])=O)cc23 |
| InChI | 1S/C19H21N5O2/c1-23-9-3-4-15(23)10-13-12-21-17-7-6-14(11-16(13)17)22-19-18(24(25)26)5-2-8-20-19/h2,5-8,11-12,15,21H,3-4,9-10H2,1H3,(H,20,22)/t15-/m1/s1 |
| InChI key | YPFIYPNOWVPAPR-OAHLLOKOSA-N |
安全信息
| 象形图 |  |
| 警示用语： | Warning |
| 危险声明 | H302 - H315 - H319 - H335 |
| 预防措施声明 | P261 - P305 + P351 + P338 |
| 危险分类 | Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3 |
| 靶器官 | Respiratory system |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
m.cnreagent.com
